Published in J Appl Bacteriol on February 01, 1991
Cellulosic hydrolysate toxicity and tolerance mechanisms in Escherichia coli. Biotechnol Biofuels (2009) 1.44
Inactivation of Ascaris suum by short-chain fatty acids. Appl Environ Microbiol (2010) 0.84
Ready-to-cook fresh meal: study for shelf life prolongation. J Food Sci Technol (2016) 0.75
Efficacy of Acetic Acid against Listeria monocytogenes Attached to Poultry Skin during Refrigerated Storage. Foods (2014) 0.75
Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol (1985) 7.22
Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol (1984) 6.75
Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clin Proc (1985) 3.58
Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J Virol (1983) 3.06
Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother (1992) 2.86
Acute ileus in myxoedema. Br Med J (1977) 2.57
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology (1987) 2.53
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet Rec (1991) 1.93
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Int J Cancer (1979) 1.89
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet (1997) 1.79
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
Small intestinal malabsorption in the horse: an assessment of the specificity of the oral glucose tolerance test. Equine Vet J (1991) 1.55
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
The ecology of chloramphenicol-resistance in Salmonella typhimurium and Escherichia coli in calves with endemic salmonella infection. J Appl Bacteriol (1981) 1.53
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Experimental Salmonella enteritidis infection in chicks. Vet Rec (1989) 1.50
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Partial purification of the Epstein-Barr virus nuclear antigen(s). J Biol Chem (1983) 1.44
Natural Borna disease virus infection in cats in the United Kingdom. Vet Rec (1998) 1.43
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen. Virology (1984) 1.40
Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein. Proc Natl Acad Sci U S A (1982) 1.39
Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines. J Gen Virol (1976) 1.38
Disease conditions diagnosed in culled adult cattle sent to an abattoir either with or without a veterinary certificate. Vet Rec (1990) 1.38
Liver lobe torsion in three adult rabbits. J Small Anim Pract (2009) 1.38
Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J Natl Cancer Inst (1976) 1.36
Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen. J Virol (1984) 1.34
Attaching-effacing bacteria in animals. J Comp Pathol (2005) 1.33
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest (1981) 1.32
A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens. J Immunol Methods (1984) 1.32
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
Reovirus-like agent (rotavirus) from lambs. Infect Immun (1976) 1.30
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Immunological evidence that the nonhormone binding component of avian steroid receptors exists in a wide range of tissues and species. Biochemistry (1985) 1.29
IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma. Int J Cancer (1981) 1.28
Production of antigens associated with Epstein-Barr virus in experimentally infected lymphoblastoid cell lines. J Natl Cancer Inst (1971) 1.28
Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen. J Virol (1982) 1.25
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Salmonella dublin abortion in cattle: preliminary observations on the serological response. Vet Rec (1971) 1.21
Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20
The effect of the method of whey preparation on the clarity of whey and the Salmonella whey agglutination titre. Res Vet Sci (1972) 1.20
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
Combined chemoimmunostimulation therapy against murine leukemia. Cancer Res (1972) 1.18
The excretion of Salmonella typhimurium in the faeces of calves fed milk substitute. J Hyg (Lond) (1983) 1.17
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16
The ecology of drug resistance in enteric bacteria. Soc Appl Bacteriol Symp Ser (1986) 1.16
Stress-related activation of Epstein-Barr virus. Brain Behav Immun (1991) 1.14
Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol (2000) 1.13
Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother (1992) 1.13
In vitro and in vivo investigations on antibody-dependent cellular cytotoxicity. Curr Top Microbiol Immunol (1978) 1.13
Pathological changes in the small intestine of neonatal calves with enteric colibacillosis. Vet Pathol (1978) 1.13
Gasterophilus nasalis infection: prevalence and pathological changes in equids in south-west England. Vet Rec (2000) 1.11
Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand (2006) 1.11
The biotyping of Escherichia coli isolated from healthy farm animals. J Hyg (Lond) (1982) 1.11
Purification and biologic characterization of a major Epstein Barr virus-induced membrane glycoprotein. J Immunol (1982) 1.10
Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus. J Virol (1985) 1.10
Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother (1994) 1.09
Induction of tetracycline resistance in Staphylococcus aureus in the absence of lipid synthesis. J Gen Microbiol (1975) 1.08
Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B. Virology (1987) 1.08
Isolation of a T-lymphotropic lentivirus from a persistently leucopenic domestic cat. Vet Rec (1988) 1.08
Towards new business models for R&D for novel antibiotics. Drug Resist Updat (2011) 1.08
Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J Antimicrob Chemother (1986) 1.08
Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl- L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol (1999) 1.07
SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob Agents Chemother (1995) 1.07
Salmonella dublin abortion in cattle. I. Observations on the serum agglutination test. J Hyg (Lond) (1973) 1.07
Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother (1992) 1.06
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer (1983) 1.06
Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.06
The growth of Salmonella dublin and Salmonella typhimurium on MacConkey media containing brilliant green. Med Lab Technol (1974) 1.05